Q/C Technologies Inc. Common Stock (QCLS)
Stock · NASDAQ · Health Care
$0.5357as of 10/16/2026
Price chart
Active signals
QCLS Signal Track Record
How signals performed across all stocks →What QCLS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 20 | -17.0% | 25% | September 14, 2026 |
| Bollinger Band Breakout | 20 | -21.0% | 20% | May 28, 2026 |
| Volume Spike | 18 | -27.7% | 6% | September 1, 2026 |
| 200-Day Moving Average TouchActive now | 6 | -19.2% | 17% | June 15, 2026 |
| Any 20-session window (baseline) | -14.7% | 25% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About QCLS
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowe…
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Employees
- 3
- Website
- ir.qctechnologies.com/
Fundamentals
- 1-day range
- $0.522$0.5896
- Market cap
- $21.99M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-3.83
- Dividend yield
- —
- Beta
- 2.19
- Avg. volume
- 4.97M
Q/C Technologies Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- QCLSQ/C Technologies Inc. Common Stock$0.538▼ 3.58%Market cap $21.99MP/E —$0.4201$8.17
- VNRXVolitionRX Limited Common Stock$0.18▼ 5.26%Market cap $9.23MP/E —$0.18$10.31
- TRIBTrinity Biotech plc American Depositary Shares$8.03▲ 1.26%Market cap $7.86MP/E —$5.01$52.5
- BMRABiomerica Inc. Common Stock$1.85▼ 1.60%Market cap $4.94MP/E —$1.45$3.21
- CDIOCardio Diagnostics Holdings Inc. Common stock$1.69▼ 3.98%Market cap $4.91MP/E —$0.97$7.91
- VRAXVirax Biolabs Group Limited Ordinary Shares$1.45▼ 10.49%Market cap $2.21MP/E —$1.55$21.75
- CDIOWCardio Diagnostics Holdings Inc. Warrant$0.0064▼ 28.09%Market cap $50.3KP/E —$0.0052$0.0721
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| QCLS Q/C Technologies Inc. Common Stock | $21.99M | — | $0.538 | ▼ 3.58% | $0.4201$8.17 |
| VNRX VolitionRX Limited Common Stock | $9.23M | — | $0.18 | ▼ 5.26% | $0.18$10.31 |
| TRIB Trinity Biotech plc American Depositary Shares | $7.86M | — | $8.03 | ▲ 1.26% | $5.01$52.5 |
| BMRA Biomerica Inc. Common Stock | $4.94M | — | $1.85 | ▼ 1.60% | $1.45$3.21 |
| CDIO Cardio Diagnostics Holdings Inc. Common stock | $4.91M | — | $1.69 | ▼ 3.98% | $0.97$7.91 |
| VRAX Virax Biolabs Group Limited Ordinary Shares | $2.21M | — | $1.45 | ▼ 10.49% | $1.55$21.75 |
| CDIOW Cardio Diagnostics Holdings Inc. Warrant | $50.3K | — | $0.0064 | ▼ 28.09% | $0.0052$0.0721 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Q/C Technologies Announces Research Collaboration with Sandia National Laboratories, a $5 Billion U.S. Department of Energy LabYahoo · 10/1/2026
- Q/C Technologies Announces Research Collaboration With Sandia National Laboratories On Optical Chips For AI Inferencebenzinga · 9/30/2026
- Securitize shares are trading higher after Rosenblatt initiated its coverage on the stock with a Buy rating and announced a price target of $14.Benzinga · 9/25/2026
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga · 9/24/2026
- Top movers in Thursday's sessionChartMill · 9/17/2026
- Which stocks have an unusual volume on Thursday?ChartMill · 9/17/2026
- Let's uncover which stocks are experiencing notable gaps during today's session.ChartMill · 9/17/2026
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga · 9/17/2026
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga · 9/17/2026
Insider Activity
Insider Actions →- Joshua Silverman · October 1, 2026 · Grant77.4K
- Joshua Silverman · July 10, 2026 · Grant16.6K
- Joshua Silverman · April 13, 2026 · Grant16.8K
- Billy Joe White · April 13, 2026 · Grant50.0K
- Voss Chelsea Sierra · April 13, 2026 · Grant50.0K
- Joshua Silverman · April 13, 2026 · Grant100.0K
- Joshua Silverman · April 13, 2026 · Grant162.2K
- Glass Mitchell · April 13, 2026 · Grant50.0K
- Friscia Stephen · April 13, 2026 · Grant50.0K
- Bruce Bernstein · April 13, 2026 · Grant50.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 612.0K
- Total value held
- $2.02M
- Institutional holders
- 17
- Unknown211.4K
- Unknown126.2K
- Unknown78.0K
- Unknown50.0K
- Unknown47.4K
- Unknown37.5K
- Unknown22.4K
- Unknown19.1K
- Unknown12.9K
- Unknown3.5K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Rosenblatt initiates coverage on Securitize with Buy rating
Securitize shares rose after Rosenblatt started tracking the stock with a Buy rating and a $14 price target. This analyst action provides new external validation for the company, which is currently trading near the lower end of its 52-week range.
Rosenblatt initiates coverage on Securitize with Buy rating. Securitize shares rose after Rosenblatt started tracking the stock with a Buy rating and a $14 price target. This analyst action provides new external validation for the company, which is currently trading near the lower end of its 52-week range.